Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Cancer. 2015 Mar 10;121(12):1937–1948. doi: 10.1002/cncr.29310

Figure 5.

Figure 5

Figure 5

Cost of chemotherapy regimens (including chemotherapy, trastuzumab, and growth factor support) in 2006, 2009 and 2014 for (A) trastuzumab-based regimens and (B) non–trastuzumab-based regimens. AC indicates doxorubicin and cyclophosphamide; ACTH, doxorubicin, cyclophosphamide, paclitaxel, and trastuzumab; TAC, docetaxel, doxorubicin, and cyclophosphamide; TC, docetaxel and cyclophosphamide; TCH, docetaxel, carboplatin, and trastuzumab.